MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/100/0.1/21.03.25 Stock

Warrant

DE000MG4D2K4

Market Closed - Börse Stuttgart 03:05:31 2024-07-16 pm EDT
0.24 EUR +4.35% Intraday chart for MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/100/0.1/21.03.25
Current month-25.00%
1 month-42.86%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-16 0.24 +4.35%
24-07-15 0.23 -36.11%
24-07-12 0.36 +9.09%
24-07-11 0.33 +10.00%
24-07-10 0.3 +7.14%

Delayed Quote Börse Stuttgart

Last update July 16, 2024 at 03:05 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN MG4D2K
ISINDE000MG4D2K4
Date issued 2024-05-16
Strike 100 $
Maturity 2025-03-21 (248 Days)
Parity 10 : 1
Emission price 1.96
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.93
Lowest since issue 0.23
Spread 0.03
Spread %11.54%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
52.79 USD
Average target price
79.72 USD
Spread / Average Target
+51.02%
Consensus